Measuring the cellular fitness of MSC has been suggested being a invaluable prognostic value for enhancing the therapeutic success (Wagner et al., 2010). pathology, regenerative medicine == Background == Mesenchymal stem cells (MSC) are multipotential precursor cells that maintain and repair tissues in the body of adult individuals. MSC have been isolated from embryonic tissues as well as from adult up to advanced ages (Landgraf et al., 2011; Batsali et al., 2013; Beane et al., 2014a; Todeschi et al., 2015). Yet experimental knowledge aboutin vivoactivities in regenerating models is still scarce (Wang et al., 2013a; Zhao et al., 2015). Besides replenishing mesenchymal tissues, MSC also modulate haematopoiesis as well as immune response (Pontikoglou et al., 2011; Hao et al., 2012; Law and Chaudhuri, 2013; Bianco, 2014). Conceivably residing in perivascular locations, MSC are identified with cells better known as pericytes. This cell type is involved in maintaining blood vessel integrity under normal conditions. During tissue damage and injury, MSC are thought to become instantaneously activated and by evading from their perivascular niche to support wound healing and tissue regeneration (Murray et al., 2014; Wong et al., 2015). MSC are acknowledged for their potential to regenerate damaged tissue due to their ability to terminally differentiate into a broad variety of cell types. Deliberately, stem cells are perceived being ageless by nature. Yet, it is by now generally accepted that, with advancing age, a decline of stem cell function and activity has its share in delaying the replacement and the turnover of damaged cells in compromised renewable tissues (Bajek et al., 2012; Bethel et al., 2013). Also, stem cells in their niches are exposed to threads such as reactive oxygen species, harmful chemical brokers or physical stresses, which trigger premature senescence, provoke accelerated cell death or cellular transformation (Li et al., 2014a). In osseous tissues at an advanced age, both mass and mineral density of cortical and cancellous bone steadily MIK665 decreases. At the same time, fat cells emerge within the bone marrow and muscles. Fat cell-specific expedition of systemically deteriorating adipokines and pro-inflammatory cytokines primes the emergence of age-associated diseases. Hence, older or senescent circumstances call for advanced therapies (Reitinger et al., 2015). Scientific approaches aiming at standardized medical treatment often neglect these biological and patho-physiological constraints. Nevertheless, these should be distinctly considered. Otherwise rightly conceived and diligently established strategies are bound to fail. == Unresolved questions regarding phenotypic appearance andin vitrotechniques == == Biological properties == Stromal cell types exhibit characteristic features. The rather large spindle-shaped cells present microvilli on their surface and produce extracellular matrix, which together facilitates MSC to firmly stick to cell culture plastic (Friedenstein, 1976; Castro-Malaspina et al., 1980). This property is often exploited to isolate and culture-purify MSC from biopsies (Owen and Friedenstein, 1988). Variant culture conditions significantly impact on cell adhesion MIK665 and consequently isolation outcome and MSC expansion. Therefore , inconsistencies often arise when employing inappropriate brands of cell MIK665 culture plastic and media supplements. == MSC immunophenotype == Another selection criterion for MSC is a tri-lineage differentiation potential forming osseous, adipose, and cartilaginous progenitors (Mark et al., 2013; Patrikoski et al., 2014), and a distinguished immune phenotype positive for CD105, CD73, and CD90, and negative for CD45, CD34, HLA-DR, and other markers (Dominici et al., 2006; Al-Nbaheen et al., 2013). This marker canon is not always unequivocal, as other cell types may also fulfill IL24 these criteria. MSC-like cells often exhibit differential marker expression depending on tissue origin and period of culture expansion (Gronthos et al., 1999; Wagner et al., 2005; Kaiser et al., 2007; Riekstina et al., 2008). A prominent MIK665 example is the surface marker STRO-1. Due to the availability of a highly affine monoclonal antibody, STRO-1 has not only gained popularity as a marker but also for use in cell enrichment (Stewart et al., 1999). Endothelial cells may however also express STRO-1 thus questioning the specificity of this marker (Lin et al., 2011; Ning et al., 2011). Though, the likely equivalence of MSC to vascular pericytes reconciles STRO-1 being a good marker for true MSC (Feng et al., 2011; Chen et al., 2012; da Silva Meirelles et al., 2015). Another currently debated marker is CD34. Previously, MSC were considered CD34 negative, yet adipose-derived MSC express CD34 (Lin et al., 2008; Baer, 2014). Likewise, CD271 and CD146 markers have also been described (Rasini et al., 2013; Busser et al., 2015; Cuthbert et al., 2015). During culture expansion marker expression can change. Whether, these changes reflect the biological age.